DZ Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

DZ Bank’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$538K	Hold	1,834	–	–	﹤0.01%	816
2026 Q1	$511K	Buy	+1,834	New	+$528K	﹤0.01%	805
2024 Q2	–	Sell	-1,936	Closed	-$670K	–	1032
2024 Q1	$670K	Hold	1,936	–	–	﹤0.01%	744
2023 Q4	$625K	Hold	1,936	–	–	﹤0.01%	720
2023 Q3	$694K	Hold	1,936	–	–	﹤0.01%	687
2023 Q2	$734K	Buy	+1,936	New	+$788K	﹤0.01%	710
2022 Q3	–	Sell	-5,971	Closed	-$2.96M	–	1018
2022 Q2	$2.96M	Sell	5,971 -11,344	-66%	-$5.91M	0.01%	538
2022 Q1	$9.75M	Buy	17,315 +11,663	+206%	+$7.03M	0.01%	376
2021 Q4	$4.28M	Buy	+5,652	New	+$4.23M	﹤0.01%	630

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

DZ Bank's BIO Position: Q2 2026 in Review

DZ Bank held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 1,834 shares worth $538K. The position accounts for ﹤0.01% of the portfolio, ranked #816.

DZ Bank first reported a position in BIO in Q4 2021 and has held it in 9 quarters since. The position peaked at $9.75M in Q1 2022. 398 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

DZ Bank held 1,834 shares of Bio-Rad Laboratories Class A worth $538K as of Q2 2026.
DZ Bank left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
Bio-Rad Laboratories Class A made up ﹤0.01% of DZ Bank's portfolio in Q2 2026, its #816 holding.
DZ Bank first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 9 quarters since.
DZ Bank's Bio-Rad Laboratories Class A position peaked at $9.75M in Q1 2022.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on DZ Bank's 13F filing for Q2 2026, filed 14 Aug 2026.